Journal article · 2026 · Open access

NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases

Yati Sharma, Aman Shrivastava, Jeetendra Kumar Gupta, Rashmi Mishra, Abhishek Dwivedi, Prerna Chaturvedi, Sumeet Dwivedi

Gene Expression, 25(2), e00086 · Published 20 April 2026 · DOI 10.14218/ge.2025.00086

Free PDFView at the publisherCite this paper

In brief

“NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases” is a 2026 journal article by Yati Sharma and 6 co-authors, published in Gene Expression. OpenAlex counts 2 citations as of 15 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Gene Expression.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
3.82
References
61
Authors
7

Abstract

The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) family regulates fundamental processes in both innate and adaptive immunity. Aberrant NF-κB activation, whether through canonical or non-canonical signaling pathways, contributes to chronic inflammation, autoimmunity, allergy, and primary immunodeficiency/autoinflammatory syndromes, while also influencing host defense and tissue repair mechanisms. The present review aims to synthesize molecular architecture, upstream triggers, ubiquitin-centered relay systems, and the dynamic regulation of NF-κB activity. The major findings on the NF-κB signaling pathway encompass its dual molecular mechanisms (canonical and non-canonical), its central roles in immune and inflammatory responses, cell survival, and development, as well as its complex regulatory networks. We interpret NF-κB as a master integrator of diverse signals, essential for both acute and long-term physiological processes. Dysregulation of NF-κB underlies many diseases, and while it is a promising therapeutic target, its ubiquitous functions demand precise modulation to avoid adverse effects. In conclusion, the proper function of the NF-κB signaling pathway is essential for maintaining cellular homeostasis and immune defense; its dysregulation is linked to chronic inflammatory diseases, autoimmune disorders, and cancer, which underscores the pathway’s significance as a therapeutic target. Although it elucidates molecular processes and treatment options, experimental validation of emerging therapeutic concepts such as ubiquitin code editing and spatial immunology remains limited.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sharma, Y., Shrivastava, A., Gupta, J. K., Mishra, R., Dwivedi, A., Chaturvedi, P., & Dwivedi, S. (2026). NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases. Gene Expression, 25(2), e00086. https://doi.org/10.14218/ge.2025.00086

MLA 9

Sharma, Yati, et al. “NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases.” Gene Expression, vol. 25, no. 2, 2026, p. e00086. https://doi.org/10.14218/ge.2025.00086.

Chicago

Sharma, Yati, Aman Shrivastava, Jeetendra Kumar Gupta, Rashmi Mishra, Abhishek Dwivedi, Prerna Chaturvedi, and Sumeet Dwivedi. 2026. “NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases.” Gene Expression 25 (2): e00086. https://doi.org/10.14218/ge.2025.00086.

Harvard

Sharma, Y. et al. (2026) ‘NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases’, Gene Expression, 25(2), p. e00086. doi:10.14218/ge.2025.00086.

IEEE

Y. Sharma et al., “NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases,” Gene Expression, vol. 25, no. 2, p. e00086, 2026, doi: 10.14218/ge.2025.00086.

BibTeX

@article{sharma2026signaling,
  title     = {{NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases}},
  author    = {Sharma, Yati and Shrivastava, Aman and Gupta, Jeetendra Kumar and Mishra, Rashmi and Dwivedi, Abhishek and Chaturvedi, Prerna and Dwivedi, Sumeet},
  journal   = {Gene Expression},
  year      = {2026},
  volume    = {25},
  number    = {2},
  pages     = {e00086},
  doi       = {10.14218/ge.2025.00086},
  url       = {https://doi.org/10.14218/ge.2025.00086}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways

  • NF-κB signaling
  • canonical NF-κB signaling
  • non-canonical NF-κB signaling
  • ubiquitin code
  • ubiquitin ligase
  • chronic inflammation
  • autoimmunity
  • allergy

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Sharma, Y., Shrivastava, A., Gupta, J. K., Mishra, R., Dwivedi, A., Chaturvedi, P., & Dwivedi, S. (2026). NF-κB Signaling Pathway: A Central Hub in the Pathogenesis and Therapeutic Targeting of Immunological Diseases. Gene Expression, 25(2), e00086. https://doi.org/10.14218/ge.2025.00086

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Gene Expression.

Who wrote this paper?

Yati Sharma, Aman Shrivastava, Jeetendra Kumar Gupta, Rashmi Mishra, Abhishek Dwivedi, Prerna Chaturvedi, Sumeet Dwivedi.

What is the DOI of this paper?

10.14218/ge.2025.00086. The permanent link is https://doi.org/10.14218/ge.2025.00086.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.